|
已选(0)清除
条数/页： 排序方式： |
| Role of LINC00152 in non-small cell lung cancer 期刊论文
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 卷号: 21
-
  收藏 | 浏览/下载：22/0 | 提交时间：2020/10/26
LONG NONCODING RNA MESENCHYMAL TRANSITION POOR-PROGNOSIS GASTRIC-CANCER PROMOTES PROGRESSION INVASION LNCRNA PROLIFERATION KNOCKDOWN Long non-coding RNA LINC00152 Non-small cell lung cancer Proliferation Prognosis R734 2 |
| 阿帕替尼联合放化疗治疗非小细胞肺癌脑转移患者的近期疗效与安全性 期刊论文
中国肿瘤生物治疗杂志, 2020, 卷号: 27
作者: 尹雪; 胡宗涛; 徐秀理; 张文康; 崔相利 ; 高世乐
收藏 | 浏览/下载：35/0 | 提交时间：2020/10/26
non-small cell lung cancer (NSCLC) brain metastasis apatinib concurrent radiochemotherapy short-term efficacy safety 非小细胞肺癌 脑转移 阿帕替尼 同步放化疗 近期疗效 安全性 |
| Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study 期刊论文
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 卷号: 25
作者: Wang Xueqian; Zhang Ying; Hou Wei; Wang Yingtian; Zheng Jiabin; Li Jie; Lin Lizhu; Jiang Yilan; Wang Shenyu; Xie Ying; Zhang Hongliang; Shu Qijin; Li Ping; Wang Wei; You Jianliang; Li Ge; Liu Jie; Fan Huiting; Zhang Meiying; Lin Hongsheng
收藏 | 浏览/下载：25/0 | 提交时间：2020/10/26
CELL LUNG-CANCER ADJUVANT CHEMOTHERAPY Chinese medicine non-small cell lung cancer postoperative care cohort study disease-free survival |
| Prevalence and clinical significance of pathogenic germline BRCA1 2 mutations in Chinese non-small cell lung cancer patients 期刊论文
Cancer Biology & Medicine, 2019, 卷号: 16
作者: Hu Xingsheng; Yang Dongyong; Li Yalun; Li Li; Wang Yan; Chen Peng; Xu Song; Pu Xingxiang; Zhu Wei; Deng Pengbo; Yen Junyi; Zhang Hanhan; Lizaso Analyn; Liu Hao; Mao Xinru; Huang Hai; Chu Qian; Hu Chengping
收藏 | 浏览/下载：61/0 | 提交时间：2020/12/28
SUSCEPTIBILITY LOCUS PROSTATE-CANCER OVARIAN-CANCER BREAST RISK MULTICENTER EXPRESSION INHIBITORS VARIANTS CARRIERS Germline BRCA mutations non-small cell lung cancer prevalence BRCA1 BRCA2 |
| Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
收藏 | 浏览/下载：33/0 | 提交时间：2020/10/26
EGFR MUTATIONS GEFITINIB TREATMENT 1ST-LINE TREATMENT OPEN-LABEL RARE MULTICENTER ERLOTINIB GENE CHEMOTHERAPY EFFICACY Non-small cell lung cancer EGFR uncommon mutation target therapy |
| Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice 期刊论文
ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38
-
收藏 | 浏览/下载：30/0 | 提交时间：2020/10/26
BRAIN METASTASES CEREBROSPINAL-FLUID GEFITINIB INHIBITORS CARCINOMA RADIATION ERLOTINIB afatinib tyrosine kinase inhibitor non-small cell lung cancer brain metastasis pharmacokinetic/pharmacodynamics pEGFR |
| Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significance 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2014, 卷号: 26
-
收藏 | 浏览/下载：35/0 | 提交时间：2020/10/26
ENDOTHELIAL GROWTH-FACTOR TUMOR-CELLS CARCINOMA NEUROPILIN-1 RECEPTORS VEGF(165) Non-small cell lung cancer (NSCLC) vascular endothelial growth factor receptor 2 (VEGFR2) neuropilin-1 (NRP-1) fluorescence in situ hybridization (FISH) |
| Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy 期刊论文
CHINESE MEDICAL JOURNAL, 2014, 卷号: 127
-
收藏 | 浏览/下载：28/0 | 提交时间：2020/10/26
PREVIOUSLY TREATED PATIENTS TYROSINE KINASE INHIBITORS FACTOR RECEPTOR MUTATIONS SKIN RASH ERLOTINIB EFFICACY GEFITINIB EGFR TRIAL BENEFIT ADENOCARCINOMA non-small cell lung cancer icotinib antitumor activity adverse events |
| Chemotherapy with or without gefitinib in patients with advanced non-small-cell lung cancer: a meta-analysis of 6844 patients 期刊论文
CHINESE MEDICAL JOURNAL, 2013, 卷号: 126
-
收藏 | 浏览/下载：27/0 | 提交时间：2020/10/26
PHASE-III TRIAL PLATINUM-BASED CHEMOTHERAPY PREVIOUSLY TREATED PATIENTS JAPANESE PATIENTS RANDOMIZED-TRIAL SUPPORTIVE CARE NAIVE PATIENTS DOCETAXEL PLACEBO MULTICENTER non-small-cell-lung cancer gefitinib meta-analysis |
| Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population 期刊论文
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2013, 卷号: 14
-
收藏 | 浏览/下载：25/0 | 提交时间：2020/10/26
COLORECTAL-CANCER GENE POLYMORPHISMS CLINICAL-RESPONSE PLUS CARBOPLATIN REPAIR GENES SURVIVAL ERCC1 ASSOCIATION PLATINUM FOLATE Non-small cell lung cancer Single nucleotide polymorphism Methylenetetrahydrofolate reductase Gemcitabine Excision repair cross-complementation group 1 |
